InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Perry Gregory d, 董事. Insider active across 3 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 7 reports have been recorded. Activity tracked since 17 June 2021. The latest transaction was filed on 15 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Perry Gregory d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
2,450 股0Common StockSEC:0001415889-25-017613:0
1,400 股0Common StockSEC:0001415889-24-016572:0
5,856 股0Common StockSEC:0001415889-23-010290:0
1,738 股Common StockSEC:0001415889-23-009142:0
20,000 股0Common StockSEC:0001415889-21-003123:0
21,417 股Common StockSEC:0001104659-16-095972:0
1,250 股Common StockSEC:0001179110-16-016917:0
7 条申报中的 7 条
About Perry Gregory d
Gregory D. Perry is a Board Member at Kala Pharmaceuticals, Inc. He is involved in the governance of the company, bringing his expertise to guide strategic decisions and ensure regulatory compliance.
